
ISONIAZID walang description

Die, TB, Die! A pharmacology presentation on the drugs used to treat active and latent Tuberculosis. A group of OUCOM PCC students make an interactive presentation. Enjoy! A 35-year-old female patient presents with symptoms that include a productive cough, fever, night sweats, and weight loss. Sputum is submitted for smear, culture, and susceptibility testing. The sputum smear is positive for acid-fast bacilli (AFB) and a chest X-ray reveals upper lobe, patchy infiltrates. Laboratory tests requested include complete blood count (CBC), liver function enzymes, bilirubin, creatinine, and uric acid. The patient is hospitalized and is to remain in isolation during drug treatment until sputum becomes smear negative. 1) Describe the recommended regimen (first-line drugs) for the treatment of active tuberculosis. What is the duration of treatment? What is meant by the term first-line drugs and how do they differ from second-line drugs for the treatment of tuberculosis? 2) Many bacterial infections can be treated with a single antimicrobial agent. Why are so many drugs needed in combination for the treatment of active cases of Mycobacterium tuberculosis? Are the same number of drugs (multiple agents) indicated for the treatment of latent tuberculosis infection? 3) Describe the mechanism of action of each of the first-line agents. 4) In regard to isoniazid, discuss 'rapid' versus 'slow' acetylators. 5) For isoniazid, describe the adverse effects that may accompany its administration. What ...

Unnecessary drugs for asthma patients? [CNN: 5-23-2011] Subscribe for news updates every 10 minutes. Like/Dislike, Favorite, Comment, Embed on Blog, Facebook Share, and Tweet this video. Get the word out on this video. Get an email once a day Like on Facebook to get updates Follow on Twitter to get updates - Monday May 23 2011 7:25 pm Tuberculosis treatment refers to the medical treatment of the infectious disease tuberculosis (TB). Active tuberculosis will kill about two of every three people affected if left untreated. Treated tuberculosis has a mortality rate of less than 5%. The standard 'short' course treatment for TB is isoniazid, rifampicin (also known as rifampin in the United States), pyrazinamide, and ethambutol for two months, then isoniazid and rifampicin alone for a further four months. The patient is considered cured at six months (although there is still a relapse rate of 2 to 3%). For latent tuberculosis, the standard treatment is six to nine months of isoniazid alone. If the organism is known to be fully sensitive, then treatment is with isoniazid, rifampicin, and pyrazinamide for two months, followed by isoniazid and rifampicin for four months. Ethambutol need not be used. All first-line anti-tuberculous drug names have a standard three-letter and a single-letter abbreviation:The US commonly uses abbreviations and names that are not internationally recognised: rifampicin is called rifampin and abbreviated RIF; streptomycin is commonly abbreviated SM. Drug ...

THRio - Tuberculosis Prevention in Rio de Janeiro - Part 1 CREATE - The Consortium to Respond Effectively to the AIDS/TB Epidemic is a non-profit organization funded by the Bill and Melinda Gates Foundation. Tuberculosis is the major cause of death in people living with HIV. CREATE's objective is to change global policy on Tuberculosis and HIV by scientific evidence, conducting clinical trials in three countries: Brazil, Zambia and South Africa. CREATE's clinical trials look at reducing the incidence of TB in whole communities by using Isoniazid Preventive Therapy (IPT), a prevention treatment that reduces the risk of developing TB disease. THRio - TB and HIV in Rio - is a clinical trial conducted in 29 HIV clinics in Rio de Janeiro. Preliminary data suggests IPT reduces the risk of developing TB disease in 80% when use in conjunction with antiretrovirals.

DOTS PLUS FOR MDR TB This young lady was in her 8th class when first diagnosed to have tuberculosis of the lungs. She was very irregular in her first treatment of CAT I of DOTS which was started for her. The disease recurred and she was put on CAT II treatment of DOTS...a treatment which is given for 8 to 9 months. She was irregular even during this treatment, skipping drugs for weeks together despite our staff's endeavors to make her adhere to the treatment. After her second treatment for TB she got a third attack of TB and was put again on CAT II and was subsequently asked to get a culture test done to rule out MDR TB ie multi-drug resistant TB. The report was that she was no longer responding to two chief drugs used to kill the TB bacilli...Rifamycin and Isoniazid. She started to get DOTS PLUS treatment which is also called CAT IV. She has been on this treatment since early 2009. During this time, the death of one of a school mate known to her of TB made this young woman to realize the seriousness of her condition. She has been taking her drugs very regularly this time and luckily for her she is responding well to the drugs, her sputum became negative for TB bacilli by the end of six months of treatment and is now in the continuation phase of treatment. She needs to take drugs daily under this CAT IV. This being October of 2010, she needs to take approx. another5 months of drugs before she is declared cured of MDR TB. We do hope that her sputum will continue to remain negative in the ...

Thibela TB - South Africa Tuberculosis Prevention - Part 2 CREATE - The Consortium to Respond Effectively to the AIDS/TB Epidemic is a non-profit organization funded by the Bill and Melinda Gates Foundation. Tuberculosis is the major cause of death in people living with HIV. CREATE's objective is to change global policy on Tuberculosis and HIV by scientific evidence, conducting clinical trials in three countries: Brazil, Zambia and South Africa. CREATE's clinical trials look at reducing the incidence of TB in whole communities by using Isoniazid Preventive Therapy (IPT), a prevention treatment that reduces the risk of developing TB disease. Thibela TB is the trial conducted in South Africa at the gold miners' community. There are more than 27000 miners enrolled in the study.

Hepatitis C Breakthrough? [NBC: 5-24-2011] Subscribe for news updates every 10 minutes. Like/Dislike, Favorite, Comment, Embed on Blog, Facebook Share, and Tweet this video. Get the word out on this video. Get an email once a day Like on Facebook to get updates Follow on Twitter to get updates - Tuesday May 24 2011 5:25 pm The terms pharmacogenomics and pharmacogenetics tend to be used interchangeably, and a precise, consensus definition of either remains elusive. Pharmacogenetics is generally regarded as the study or clinical testing of genetic variation that gives rise to differing response to drugs, while pharmacogenomics is the broader application of genomic technologies to new drug discovery and further characterization of older drugs. Pharmacogenetics refers to genetic differences in metabolic pathways which can affect individual responses to drugs, both in terms of therapeutic effect as well as adverse effects. Much of current clinical interest is at the level of pharmacogenetics, involving variation in genes involved in, drug metabolism with a particular emphasis on improving drug safety. The wider use of pharmacogenetic testing is viewed by many as an outstanding opportunity to improve prescribing safety and efficacy. Driving this trend are the 106000 deaths and 2. 2 Million serious events caused by adverse drug reactions in the US each year (Lazarou 1998). As such ADRs are responsible for 5-7% of hospital admissions in the US and Europe, lead to the ...

Thibela TB - South Africa Tuberculosis Prevention - Part 1 CREATE - The Consortium to Respond Effectively to the AIDS/TB Epidemic is a non-profit organization funded by the Bill and Melinda Gates Foundation. Tuberculosis is the major cause of death in people living with HIV. CREATE's objective is to change global policy on Tuberculosis and HIV by scientific evidence, conducting clinical trials in three countries: Brazil, Zambia and South Africa. CREATE's clinical trials look at reducing the incidence of TB in whole communities by using Isoniazid Preventive Therapy (IPT), a prevention treatment that reduces the risk of developing TB disease. Thibela TB is the trial conducted in South Africa at the gold miners' community. There are more than 27000 miners enrolled in the study.

Bella what's UR name?? Isoniazid

The Last Pill My diagnosis of Latent Tuberculosis has had me eat one pill of isoniazid every day for 9 months. This is the last pill. If I am well, there will be no more!!! If you're interested in learning...

Unnecessary drugs for asthma patients? [CNN: 5-23-2011] Subscribe for daily health news. Like/Dislike, Favorite, Comment, Embed on Blog, Facebook Share, and Tweet this video. Get the word out on this video. - Tuesday May 24 2011 12:01 am Tuberculosis treatment refers to the medical treatment of the infectious disease tuberculosis (TB). Active tuberculosis will kill about two of every three people affected if left untreated. Treated tuberculosis has a mortality rate of less than 5%. The standard 'short' course treatment for TB is isoniazid, rifampicin (also known as rifampin in the United States), pyrazinamide, and ethambutol for two months, then isoniazid and rifampicin alone for a further four months. The patient is considered cured at six months (although there is still a relapse rate of 2 to 3%). For latent tuberculosis, the standard treatment is six to nine months of isoniazid alone. If the organism is known to be fully sensitive, then treatment is with isoniazid, rifampicin, and pyrazinamide for two months, followed by isoniazid and rifampicin for four months. Ethambutol need not be used. All first-line anti-tuberculous drug names have a standard three-letter and a single-letter abbreviation:The US commonly uses abbreviations and names that are not internationally recognised: rifampicin is called rifampin and abbreviated RIF; streptomycin is commonly abbreviated SM. Drug regimens are similarly abbreviated in a standardised manner. The drugs are listed using their single letter abbreviations (in the order ...

19. Tuberculosis (II): After Robert Koch Epidemics in Western Society Since 1600 (HIST 234) The cultural transition from the romantic era of consumption to the era of tuberculosis derived not only from the germ theory of disease and the triumph of contagionism over anticontagionism, but also from political considerations. Worries over population decline and growing working-class militancy were aggravated by what now appeared to be a social disease, or a disease of poverty. One of the strategies deployed against the disease was the sanatorium, an institution which was capable both of instructing patients in contagionism and in imposing a practical quarantine. Although the development of effective chemotherapy in the 1940s raised hopes that tuberculosis might be globally eradicated, these have unfortunately proven to be overly optimistic. Factors such as poverty and population displacement continue to favor the disease's spread today, particularly in the Third World. Complete course materials are available at the Open Yale Courses website: open.yale.edu This course was recorded in Spring 2010.

THRio - Tuberculosis Prevention in Rio de Janeiro - Part 2 CREATE - The Consortium to Respond Effectively to the AIDS/TB Epidemic is a non-profit organization funded by the Bill and Melinda Gates Foundation. Tuberculosis is the major cause of death in people living with HIV. CREATE's objective is to change global policy on Tuberculosis and HIV by scientific evidence, conducting clinical trials in three countries: Brazil, Zambia and South Africa. CREATE's clinical trials look at reducing the incidence of TB in whole communities by using Isoniazid Preventive Therapy (IPT), a prevention treatment that reduces the risk of developing TB disease. THRio - TB and HIV in Rio - is a clinical trial conducted in 29 HIV clinics in Rio de Janeiro. Preliminary data suggests IPT reduces the risk of developing TB disease in 80% when use in conjunction with antiretrovirals.